title: EPCAM deletions, Lynch syndrome, and cancer risk.
authors.affiliation: Department of Preventive Medicine and Public Health, Creighton University, 2500 California Plaza, Omaha, NE, USA. htlynch@creighton.edu
authors.forename: Henry T
authors.initials: HT
authors.lastname: Lynch
authors.forename: Jane F
authors.initials: JF
authors.lastname: Lynch
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Snyder
authors.forename: Douglas
authors.initials: D
authors.lastname: Riegert-Johnson
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics*; D015815:Cell Adhesion Molecules / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000209:etiology*; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000235:genetics*; D016889:Endometrial Neoplasms / Q000209:etiology*; D000071858:Epithelial Cell Adhesion Molecule; D005260:Female; D017353:Gene Deletion; D006801:Humans; D051718:MutS Homolog 2 Protein / Q000235:genetics; D009154:Mutation; D012306:Risk
chemical_list: D000951:Antigens, Neoplasm; D015815:Cell Adhesion Molecules; C499379:EPCAM protein, human; D000071858:Epithelial Cell Adhesion Molecule; C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein